Annual Report

Overview

The report describes UCB's 2015 growth phase, with consolidated revenue of € 3 876 million and 7 788 employees worldwide. It emphasizes the Patient Value Strategy and four main medicines, which accounted for 77% of net sales. The CSR reporting covers Scope 1, Scope 2 and business-travel Scope 3 emissions and reports no work-related fatalities. The CSR Performance Report is stated to be in accordance with GRI G4 Core and includes PwC limited assurance over selected indicators.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2015
Period: Ends 31 December 2015
Language: English
Pages
File size

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services